{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:azacitidine-injection",
  "slug": "azacitidine-injection",
  "title": "FDA shortage status: Azacitidine Injection",
  "ingredient": "Azacitidine Injection",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "AZACITIDINE",
    "VIDAZA"
  ],
  "therapeutic_categories": [
    "Oncology"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAVENOUS",
    "SUBCUTANEOUS"
  ],
  "package_count": 9,
  "packages": [
    {
      "package_ndc": "16729-306-10",
      "product_ndc": "16729-306",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Azacitidine, Injection, 100 mg (NDC 16729-306-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/21/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72485-201-01",
      "product_ndc": "72485-201",
      "company_name": "Armas Pharmaceuticals Inc",
      "manufacturer_name": "Armas Pharmaceuticals Inc.",
      "presentation": "Azacitidine, Injection, 100 mg (NDC 72485-201-01)",
      "availability": "Limited Availability",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "06/08/2026",
      "initial_posting_date": "12/18/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "59572-102-01",
      "product_ndc": "59572-102",
      "company_name": "Bristol Myers Squibb Co.",
      "manufacturer_name": "Celgene Corporation",
      "presentation": "Vidaza, Injection, 100 mg (NDC 59572-102-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/16/2026",
      "initial_posting_date": "12/18/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43598-305-62",
      "product_ndc": "43598-305",
      "company_name": "Dr. Reddy's Laboratories, Inc.",
      "manufacturer_name": "Dr. Reddy's Laboratories Inc.",
      "presentation": "Azacitidine, Injection, 100 mg (NDC 43598-305-62)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/05/2026",
      "initial_posting_date": "12/18/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-393-01",
      "product_ndc": "55150-393",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "12/22/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-771-39",
      "product_ndc": "63323-771",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "12/18/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9606-01",
      "product_ndc": "0143-9606",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "12/18/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-115-30",
      "product_ndc": "71288-115",
      "company_name": "Meitheal Pharmaceuticals, Inc.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc.",
      "presentation": "Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "12/18/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68001-313-56",
      "product_ndc": "68001-313",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "BluePoint Laboratories",
      "presentation": "Azacitidine, Injection, 100 mg (NDC 68001-313-56)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS",
        "SUBCUTANEOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "12/22/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 5,
    "Limited Availability": 1,
    "Unavailable": 3
  },
  "initial_posting_date": "12/18/2020",
  "latest_source_update": "08/17/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}